key: cord-0324119-gmjeed29
authors: Vasaghi Gharamaleki, M.; Mousavi, S. Z.; Owrangi, M.; Gholamzadeh, M. J.; Kamali, A.-M.; Dehghani, M.; Chakrabarti, P.; Nami, M.
title: Neural Correlates and Functional Cognitive Maps in Breast Cancer Survivors Receiving Different Chemotherapy Regimens; a QEEG/HEG-based Investigation
date: 2021-08-31
journal: nan
DOI: 10.1101/2021.08.28.21262758
sha: 9a5baaf1e4cd07d3e80440c5411f00db6995e0d1
doc_id: 324119
cord_uid: gmjeed29

Background: Post-chemotherapy cognitive impairment commonly known as "chemobrain" or "chemofog" is a well-established clinical disorder affecting various cognitive domains including attention, visuospatial working memory, executive function, etc. Although several studies have confirmed the chemobrain in recent years, scant experiments have evaluated the potential neurotoxicity of different chemotherapy regimens and agents. In this study, we aimed to evaluate the extent of attention deficits, one of the commonly affected cognitive domains, among breast cancer patients treated with different chemotherapy regimens through neuroimaging techniques. Methods: Breast cancer patients treated with two commonly prescribed chemotherapy regimens, AC-T and TAC, and healthy volunteers were recruited. Near-infrared hemoencephalography (nirHEG) and quantitative electroencephalography (qEEG) assessments were recorded for each participant at rest and during task performance to compare the functional cortical changes associated with each chemotherapy regimen. Results: The qEEG analysis revealed increased power of high alpha/low beta or sensorimotor rhythm (SMR) frequency in left fronto-centro-parietal regions involved in dorsal and ventral attention networks (DAN and VAN) in the AC-T-treated group comparing to the TAC and control group. The AC-T group also had the highest current source density (CSD) values in DAN and VAN-related centers in 10 and 15 Hz associated with the lowest Z-scored FFT coherence in the mentioned regions. Conclusions: The mentioned findings revealed increased cognitive workload and lack of cognitive ease in breast cancer patients treated with the AC-T regimen proposing the presumable neurotoxic sequelae of this chemotherapy regimen in comparison with the TAC regimen.

Breast cancer is currently the most commonly diagnosed cancer and the 5th cause of cancer deaths worldwide. According to "GLOBOCAN" estimates, it accounts for about 24.5% of new cancer cases and 15.5% of cancer deaths in 2020 among females (1, 2) . It seems that both premenopausal and postmenopausal incidences of breast cancer are increasing worldwide due to lifestyle and hormonal risk factors and increased screening rates (3) . Since the improvement of diagnostic and treatment strategies has increased the breast cancer survival rate, improving survivors' quality of life (QoL) is of great importance (4) . A study conducted by Schmidt et al. revealed that although QoL in breast cancer survivors substantially improved over time, many survivors still suffered from post-chemotherapy complications with cognitive impairment as the most disabling problem (5) . Cognitive performance is one of the determinants of Qol which impairment can persist for several years in breast cancer survivors (6) (7) (8) (9) . As chemotherapy is the mainstay of breast cancer treatment, its side effects especially its neurotoxic sequelae should be considered to make less impact on the patient's QoL.

The chemotherapy-induced cognitive impairment, commonly known as "chemobrain" or "chemofog", has been reported among breast cancer survivors subjectively (10) (11) (12) (13) (14) . Multiple studies have evaluated chemobrain prevalence in breast cancer survivors suggesting that the chemobrain incidence rate can be up to 70% (13, 15) . However, these complaints have been reported more subjectively than objectively (16) (17) (18) . One explanation is that chemotherapy is associated with a subtle cognitive impairment that can be latent in neuropsychological tests though problematic in patients' real life (19) .

A meta-analysis published by Ono et al. evaluated the performance of breast cancer patients who underwent adjuvant chemotherapy in eight cognitive domains and revealed that chemotherapy has a small but significant impact on cognitive function. Although the study showed that five out of eight domains of cognitive functioning can be influenced, it seems that . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 31, 2021. ;  https://doi.org/10.1101/2021.08.28.21262758 doi: medRxiv preprint some cognitive domains including processing speed can be more affected by chemotherapy and some domains such as long-term memory can improve over time (20) .

Besides, numerous studies have attempted to assess chemobrain objectively mostly through neuroimaging assessments which were indicative of morphological changes including reduced gray matter in frontal, temporal, and parietal regions in cancer patients which correlates with cognitive decline (8, (21) (22) (23) (24) (25) . In one longitudinal study accomplished by Deprez et al. using magnetic resonance diffusion tensor imaging (DTI), changes in cerebral white matter integrity in important tracts involved in cognition were demonstrated after chemotherapy in breast cancer patients (26) . Also, another large cross-sectional study illustrated a long-term reduction in total brain volume and gray matter in cancer patients who received adjuvant chemotherapy via structural MRI (27) . Moreover, applying fMRI has shown alterations in brain activation patterns particularly in the frontal lobe during tasks involving cognitive domains such as working memory in the chemotherapy-exposed patients (28) . Nevertheless, limited studies have evaluated the impact of chemotherapy on functional brain network alterations by electroencephalography (EEG) (29) .

On the other hand, Various chemotherapy regimens are used as adjuvant therapy to reduce mortality and recurrence in HER2-negative breast cancer. Selection of the appropriate regimen should be individualized regarding the patient's characteristics. However, adverse effects and long-term complications of each regimen should be exactly monitored to help physicians prescribing the less toxic regimen. For most patients in whom chemotherapy is indicated, the selected regimen is dose-dense doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T), known as the AC-T regimen. Another alternative is the TAC regimen in which docetaxel plus doxorubicin and cyclophosphamide are administered (30, 31) . Despite vast research assessing the relationship between chemotherapy and cognitive decline, scant studies have compared neurotoxic effects of common chemotherapy regimens. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Therefore, as response inhibition, visuospatial working memory, and sustained attention have shown a significant decline in chemotherapy-treated patients which provoke neuronal activation in DAN and , we aim to assess the functional effects of the chemotherapy regimens mentioned above on these brain networks via two less commonly applied methods, electroencephalography and hemoencephalography (HEG), to determine the regimen with less neurotoxic sequela and help clinicians to make a more informed decision. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 31, 2021. ; https://doi.org/10.1101/2021.08.28.21262758 doi: medRxiv preprint

The patients and control group enrolled in our previous study were asked to participate in the current experiment. Patients were recruited from Motahari Polyclinic, the affiliated medical center of Shiraz University of Medical Sciences, between 2018 and 2020. Participants were chemotherapy-treated breast cancer patients who met the following criteria: 1) women aged is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 31, 2021. ; https://doi.org/10.1101/2021.08.28.21262758 doi: medRxiv preprint

All participants were asked to complete a demographic questionnaire including information regarding the age, marital status, education, occupation, past medical and drug history and in particular neuropsychiatric disorders, and detailed information of the underwent cancer treatments for breast cancer patients (e.g. chemotherapy regimen, radiotherapy, surgery, etc.).

Near-infrared hemoencephalography (nirHEG), a neuroimaging method of monitoring changes in cortical blood circulation and oxygenation (37) , was used in this study to measure prefrontal cortical hemodynamic changes. The NeXus-4 biofeedback and neurofeedback system (NeXus-4, Mind Media BV, Herten, the Netherlands) with a HEG sensor headband were utilized. The nirHEG headband has two optodes placed in contact with the skin, a lightgenerating LED pair for red and infrared light production, and a sensor optode to receive the returning light.

The nirHEG data were recorded from all participants at the left frontoparietal (FP1) area with the following method: 1) five minutes in resting-state sitting in a comfortable recliner with eyes open, 2) while performing one of the CBS cognitive tasks with the lowest Z score for each participant identified as the area needing improvement (ANI) according to the results of our previous study, and 3) five minutes post-test resting state with eyes open. BioTrace+ software (NeXus-4, Mind Media BV, Herten, the Netherlands) was used to analyze the HEG data.

All participants underwent quantitative electroencephalography (qEEG) assessment using a 19-electrode EEG cap, fitted for each patient. The International 10-20 system was applied for . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 31, 2021. ; https://doi.org/10.1101/2021.08.28.21262758 doi: medRxiv preprint electrode placement using a Linked Ears (LE) montage. EEG data were recorded using "NrSign EEG 3840" (NrSign Inc., Vancouver, Canada) with the sensitivity of 70 microvolts, a sampling rate of 500 samples/second, a low-cut filter at 0.5 Hz, and a high-cut filter at 70 Hz according to the following protocol: (1) five minutes in resting-state sitting in a comfortable recliner with eyes open, and then (2) while performing the ANI task.

The raw EEG data was exported to "EEG Studio Processing" software (Mitsar Co. Ltd. St.

Petersburg Russia) for pre-processing. Independent component analysis (ICA), a data decomposition method (38) , was applied to extract artifacts from neuronal activity. ICA components related to eye blink and eye movement artifacts were removed. The pre-processed EEG data was then exported as the EDF file to "NeuroGuide" software version 3.0.9 (Applied Neuroscience, Inc., St. Petersburg, FL, USA), a comprehensive digital qEEG analysis system, for advanced processing.

To confirm the selection of artifact-free qEEG segments, automatic editing was also performed through NeuroGuide software. A 10-second artifact-free segment was manually selected by an expert in qEEG analysis as the template. The artifact-free template matching tool of the NeuroGuide software with defaults of high sensitivity for drowsiness and eye movement artifact rejection and amplitude multiplier of 1.00 was then applied to perform automatic editing. The artifact-free EEG selections with test re-test reliability > 0.90 and splithalf reliability > 0.95 were confirmed for further analysis.

To display and analyze functional cognitive maps of AC-T, TAC, and control groups separately, the edited EEG files of the resting-state of members of each group were combined . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 31, 2021. ; https://doi.org/10.1101/2021.08.28.21262758 doi: medRxiv preprint to create a single text file. This text file was also imported to Neuroguide software and analyzed to produce cortical color topographic maps and other metrics including peak frequency, absolute power, relative power, coherence, phase lag, etc. representing the overall cognitive function of members of each group.

Besides, to enable the comparison, the edited artifact-free EEG selections of the restingstate of all the participants were converted to Neuroguide Analysis files (NGA) through NeuroGuide software that are of interest for comparison purposes. The Neurobatch toolbox was then applied to combine NGA files of all the members of a group and create Neuroguide Group analysis files (NGG) for the AC-T, TAC, and control groups separately. The three NGG files were then compared through group statistics analysis.

Neuronavigator analysis was also performed to assess the current source density (CSD) values, the volume density of net transmembrane currents (39) , in DAN and VAN networks.

Mean Frequencies of 10 and 15 Hz were selected to represent the high alpha and beta 1 frequency bands respectively. The Brodmann areas with the maximum CSD values in the mentioned frequencies in DAN and VAN networks among the control group were identified and selected as regions of interest (ROIs). The CSD values of these ROIs were then compared between the three groups. All the mentioned steps were furtherly repeated for analyzing the qEEG files of ANI task performance. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 31, 2021. ; https://doi.org/10.1101/2021.08.28.21262758 doi: medRxiv preprint

In total, 24 healthy volunteers and 35 chemotherapy-treated breast cancer patients that all have been enrolled in our previous study accepted to participate in the current experiment, of whom 16 patients had received the AC-T chemotherapy regimen and 19 patients had been treated with the TAC regimen. All of the patients had a biopsy report confirming the breast malignancy pathologically, negative history of brain metastasis, and underwent a total or partial mastectomy, radiotherapy, and chemotherapy. Also, 24 healthy volunteers matched with the breast cancer patients in terms of age and education enrolled in the study as the control group.

The mean ages of the participants were 48, 44.6, and 45 years for the AC-T, TAC, and control groups respectively. Regarding the education level, about 17%, 34%, and 49% of the respondents had high school, diploma, and academic degrees respectively. None of the participants had a positive history of brain surgery, stroke, epilepsy, and other neurological disorders. Demographic characteristics of the participants are summarized in table 1.

To compare the cortical blood flow among the three groups, ANOVA test was used which showed that cortical hemodynamics had no significant difference not only in resting-state but also during task performance (p-value ≥ 0.05). Post-test cortical blood flow was shown to be significantly higher in the AC-T-treated breast cancer patients than in the control group (pvalue = 0.02). The comparison between AC-T and TAC regimen and between TAC regimen and control group were not found to reveal significant differences (p-value ≥ 0.05). Moreover, repeated measures ANOVA test was used to assess the effect of task performance on cortical hemodynamics at FP1 which demonstrated increased blood flow during and after ANI task is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

The recorded qEEG files of each three groups were analyzed with the NeuroGuide software to generate the cortical color maps and statistical metrics. Since the purpose of this study was to evaluate attention deficits among chemotherapy-treated breast cancer patients and DAN and VAN networks comprise of fronto-parietal and centro-parietal regions, the fronto-centroparietal electrodes including the F3, C3, P3, F4, C4, and P4 were selected for further analysis.

The mean absolute power of these selected electrodes in beta1 and alpha frequency bands or sensorimotor rhythm (SMR) frequency is summarized in table 2. As the table indicates, the absolute power of both fronto-centro-parietal regions in SMR frequency is higher in the AC-T regimen than in the two other groups. Besides, the TAC regimen has higher absolute power in comparison to the control group. Figure 1 showed functional cortical maps representing the absolute power in beta 1 and alpha frequency bands in AC-T, TAC, and control groups during resting-state and ANI task performance.

To compare the mentioned groups, NGG analysis was conducted using the NeuroGuide software. Absolute power in the beta 1 frequency band in Cz and Pz electrodes was significantly higher in the AC-T regimen compared to the control group (p-value = 0.02 and 0.04 respectively). The AC-T group also had a significantly higher absolute power of the Cz electrode in the beta 1 frequency in comparison to the TAC regimen (p-value = 0.03).

Moreover, absolute power in the FP1 electrode in beta 1 frequency was significantly higher in the control group than in the TAC regimen (p-value = 0.03) (figure 2). Other fronto-centroparietal regions did not show significant differences. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 31, 2021. ; https://doi.org/10.1101/2021.08.28.21262758 doi: medRxiv preprint

Regarding the FFT coherence, fronto-centro-parietal electrodes with significant differences in the Z-scored FFT Coherence among the three groups (p-value ≤ 0.05) were analyzed. As it is shown in figure 3 , the AC-T and TAC regimens had a decreased Z-scored coherence (hypocoherence) in the fronto-centro-parietal regions in SMR frequency compared to the control group. However, comparing the Z-scored coherence of the mentioned regions among the AC-T and TAC groups was inconclusive. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 31, 2021. ; https://doi.org/10.1101/2021.08.28.21262758 doi: medRxiv preprint

The theory of "chemobrain" is currently well established. However, very limited studies have evaluated the neuropsychological sequelae of different chemotherapy regimens to propose the least toxic regimen. Since the breast cancer patients receiving the AC-T regimen showed worse performance in sustained attention and visuospatial working memory which are regulated through the VAN and DAN networks, in the present study, we aimed to analyze functional cortical maps of fronto-parietal and centro-parietal areas in patients receiving AC-T and TAC chemotherapy regimens. The current study has revealed increased amplitude of alpha and beta 1 frequency bands in the AC-T regimen in comparison with the TAC regimen and control groups in these neural networks. In addition, the HEG study did not show significant differences in cortical hemodynamics between mentioned groups in both resting-state and test performance. However, post-test blood flow was shown to be higher in the AC-T regimen in comparison with the control group.

It is already known that stimuli processing includes multiple levels of hierarchical analysis named global (general features of subjects) versus local attentional processing (such as the cognitive tasks performed in the current study). It has been revealed that global and local attentional processing is lateralized in the brain; global processing is associated with the right hemisphere activation and local processing with the left hemisphere. Interestingly, this hemisphere asymmetry was also shown in the pre-stimulus resting intervals leading to better functional performance (40) (41) (42) .

As observed, the mean absolute power of the beta 1 frequency band in the left fronto-centroparietal regions was higher in the AC-T regimen than in the two other groups. Besides, the is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 31, 2021. ; https://doi.org/10.1101/2021.08.28.21262758 doi: medRxiv preprint 21 in DAN and VAN networks in 15 Hz frequency. This pattern of left hemisphere activation is consistent with the hemisphere asymmetry seen in the local attentional processing.

Available literature has emphasized the important role of the beta 1 frequency band in cognitive function and particularly sustained attention (43, 44) . For instance, a study published by Solís-Vivanco et al. showed that optimal attentional performance depends on the cooperation between DAN and VAN neural networks through modification of upper alpha/low beta (SMR) oscillations. They found a power increase of beta oscillations both in VAN and DAN nodes among the participants while performing a bimodal attention task (45) . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 31, 2021. ; https://doi.org/10.1101/2021.08.28.21262758 doi: medRxiv preprint response to an increase in cognitive load. They interpreted their findings with response inhibition theory which claims an increase in occipito-parietal alpha band power is associated with inhibition of irrelevant information (56, 57) . Therefore, two distinct mechanisms can justify the synchronization and desynchronization of the alpha band. In line with this theory, in the current study, the AC-T regimen had higher alpha band power which can be indicative of more efforts for inhibition of irrelevant data and therefore increment of cognitive workload. The AC-T regimen includes administration of doxorubicin (adriamycin) and cyclophosphamide (cytoxan) every three weeks for four cycles followed by paclitaxel (taxol) for four other cycles. Among these medications, taxane-induced neuropathy is well established. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 31, 2021. ; https://doi.org/10.1101/2021.08.28.21262758 doi: medRxiv preprint Paclitaxel administration causes microtubules aggregation in nerve axons leading to degenerative axonopathy. Besides the peripheral nervous system, the CNS axons are also at risk causing paclitaxel-induced encephalopathy (60) (61) (62) . The same results were demonstrated in McElroy's study in which the effects of the AC-T regimen in female mice were assessed.

According to this study, oxidative stress resulting from the toxic effects of the AC-T regimen can lead to dendritic branching and morphologic alterations in the hippocampus besides the mitochondrial dysfunction which all contribute to cognitive dysfunction (63) . In addition, since the agents of the AC-T regimen except cyclophosphamide cannot cross the brain blood barrier, one mechanism suggested for the chemobrain phenomenon is cytokine dysregulation and is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

This qEEG-based study revealed increased amplitude of high alpha/low beta (SMR) frequency bands in left fronto-centro-parietal regions in VAN is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The mean absolute power of alpha and beta 1 frequency bands in fronto-centro-parietal electrodes in resting-state and task performance electroencephalography (EEG) data of AC-T, TAC, and control groups. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 31, 2021. ; https://doi.org/10.1101/2021.08.28.21262758 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 31, 2021. ; https://doi.org/10.1101/2021.08.28.21262758 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 31, 2021. ; https://doi.org/10.1101/2021.08.28.21262758 doi: medRxiv preprint Table 2 : The mean absolute power of alpha and beta 1 frequency bands in fronto-centro-parietal electrodes in resting-state and task performance EEG data of AC-T, TAC, and control groups.

Absolute power of beta 1 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 31, 2021. ; https://doi.org/10.1101/2021.08.28.21262758 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 31, 2021. ; https://doi.org/10.1101/2021.08.28.21262758 doi: medRxiv preprint

A systematic analysis for the global burden of disease study

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study

Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Quality of life, problems, and needs of diseasefree breast cancer survivors 5 years after diagnosis

Quality of life in long-term and very long-term cancer survivors versus population controls in Germany

Quality of life in long-term breast cancer survivors -a 10-year longitudinal population-based study

Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer

Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy

Chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial

Women's experiences of cancer-related cognitive impairment, its impact on daily life and care received for it following treatment for breast cancer

Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response

Chemotherapy-related cognitive impairment: the breast cancer experience

Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study

Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review

A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer

A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients

A Call for a Neuroscience Approach to Cancer-Related Cognitive Impairment

A metaanalysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer

Longitudinal assessment of chemotherapy-induced changes in brain and cognitive functioning: A systematic review

Prefrontal cortex and executive function impairments in primary breast cancer

Neural correlates of chemotherapy-related cognitive impairment

Structural brain alterations following adult non-CNS cancers: a systematic review of the neuroimaging literature

Chemotherapy-induced brain changes in breast cancer survivors: evaluation with multimodality magnetic resonance imaging

Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning

Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy

Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study

Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer

Breast Cancer Treatment: A Review

Adjuvant docetaxel for node-positive breast cancer

Comparative Analysis of the Chemotherapy-related Cognition Impairments in Patients with Breast Cancer: a Community-based Research

Large-scale functional neural network correlates of response inhibition: an fMRI meta-analysis

The reorienting system of the human brain: from environment to theory of mind

Sustaining attention to simple tasks: a meta-analytic review of the neural mechanisms of vigilant attention

A metaanalysis of executive components of working memory

HEMOENCEPHALOGRAPHY NEUROFEEDBACK-MECHANISM OF ACTION

Enhanced detection of artifacts in EEG data using higher-order statistics and independent component analysis

Kernel current source density method

Attending to global versus local stimulus features modulates neural processing of low versus high spatial frequencies: an analysis with event-related brain potentials

Linking time-on-task, spatial bias and hemispheric activation asymmetry: a neural correlate of rightward attention drift

Asymmetrical hemisphere activation enhances globallocal processing

Beyond the status quo: a role for beta oscillations in endogenous content (re) activation

Localization of cortical phase and amplitude dynamics during visual working memory encoding and retention

New insights on the ventral attention network: Active suppression and involuntary recruitment during a bimodal task

EEGcorrelated fMRI of human alpha activity

Where the BOLD signal goes when alpha EEG leaves

Resting EEG in alpha and beta bands predicts individual differences in attentional breadth

Electroencephalographic workload indicators during teleoperation of an unmanned aerial vehicle shepherding a swarm of unmanned ground vehicles in contested environments

Measurement of cognitive load in HCI systems using EEG power spectrum: an experimental study

Mental workload and situation awareness

Using electroencephalography to measure cognitive load

Estimating brain load from the EEG

An EEG-based cognitive load assessment in multimedia learning using feature extraction and partial directed coherence

Resting EEG in alpha and beta bands predicts individual differences in attentional blink magnitude

Effects of mental workload and fatigue on the P300, alpha and theta band power during operation of an ERP (P300) brain-computer interface

Using theta and alpha band power to assess cognitive workload in multitasking environments

Cognitive impairment after cytotoxic chemotherapy

Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study

Acute transient encephalopathy after weekly paclitaxel infusion

Nonconvulsive status epilepticus secondary to paclitaxel administration

Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel

Assessing the Effects of Redox Modifier MnTnBuOE-2-PyP 5+ on Cognition and Hippocampal Physiology Following Doxorubicin, Cyclophosphamide, and Paclitaxel Treatment

The authors would like to thank DANA Brain Health Institute; Iranian Neuroscience Society, Fars Chapter, Shiraz, Iran for the received support. The study received partial financial support from School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran (ID: 15307)